The Royal Pharmaceutical Society (RPS) has been on the lookout for innovative ideas and suggestions that could transform the future of pharmacy practice in England over the next decade.
The society's new project with the King's Fund to transform the future of pharmacy practice in England is at a consultation phase, seeking views and opinions of
pharmacy teams from all areas of practice including primary, secondary, social and community care to ensure that the system gets the best out of pharmacy and the
public receives seamless, joined-up care.
"We want to build a vision that sets out the role of and value of pharmacists and pharmacy teams working across systems, providing patient care and NHS services,"
said RPS in a statement.
"Transforming the future of pharmacy practice recognises the urgent need to build on new ways of working established across health and care systems during the
pandemic to meet the increasingly complex health needs of people and improve patient outcomes."
The government has extended VAT exemption from Monday (1 May) on healthcare services carried out by pharmacy staff under the supervision of pharmacists.
HM Revenue and Customs has issued a note detailing the change to the VAT treatment of medical services. The Government said this will bring the VAT treatment of
pharmacists in line with other registered health professionals providing medical services to the public.
The Pharmaceutical Services Negotiating Committee (PSNC) said: "This is something that PSNC has been seeking Government agreement on for a long time, including in
recent CPCF negotiations."
PSNC believes that the extension of this VAT exemption will help as community pharmacy businesses try to make better use of the skill mix in their teams both now
and in the future.
"Not only does it enable contractors to review the VAT status of any locally commissioned services currently provided by non-registered pharmacy staff but also, in
time, it could be used to amend nationally commissioned services to allow support staff to provide certain parts. For example, following a recent amendment to the
service Directions, pharmacy technicians are now able to perform blood pressure checks as part of the Hypertension Case-Finding Service and deliver the Smoking
Cessation Service.
Pharmacies and other spaces should be able to facilitate the provision of health care to bring services closer to patients and reduce demands on general
practice, suggested a report by Tony Blair Institute.
In a paper 'Modern and Sustainable NHS Providing Accessible and Personalised Care for All', it has propose six areas for reform where radical-but-practical
policy action will begin to transform the future of the NHS and deliver better patient care.
It has proposed to create new access routes for services and providers. It added: "The range and availability of health-care services must increase to reflect
citizens' demands and their increasingly complex needs.
"Pharmacies, gyms, supermarkets, workplaces and other spaces should all be able to provide or facilitate the provision of health care, bringing services closer
to patients and reducing demands on general practice.
It suggested: "We must move towards greater community-based care and the creation of a neighbourhood health service, with more routes for direct patient access,
to ensure services are available when and where people need them. These should all be accessible through a single, simple digital front door to the NHS."
The fusion of the unique in-depth understanding of medicines by pharmacists together with the competence to prescribe offers will improve access to care and
increase capacity in the health system, said the Royal Pharmaceutical Society (RPS) Director for England Ravi Sharma to Parliament at the Health and Social Care
Select Committee's inquiry on workforce on Monday (May 23).
However, he also stated that a new workforce strategy must support and harness the skills of pharmacist independent prescribers in clinical care with investment
in training, both for new and existing workforce; access to supervisors; protected learning and development time; and commissioning of services to make best use of
independent prescribers across care settings, supported by appropriate prescribing budgets in community pharmacy.
"We're about to see new generation of pharmacists independent prescribers that will make a huge difference to the clinical role of pharmacists to support patient care, but this must be underpinned by protected learning time and a more ambitious approach to commissioning new services to use their skills," Ravi said.
He spoke to MPs in Parliament at the Health and Social Care Select Committee's inquiry on workforce, highlighting the vital contribution of pharmacy teams during
the pandemic and called for action to support the current and future workforce.
Some of the key issues highlighted in the parliament included, the risk of burnout and the need to help boost staff retention; staff wellbeing, including a zero tolerance of abuse from the public; the importance of professional development and protected learning time to enhance patient care and support rewarding careers; the potential of new pharmacist independent prescribers and the need for investment in the current workforce and the need for better workforce data and a pharmacy workforce strategy.
As the countdown to the next UK election begins, the King's Fund has identified three priorities to improve public health.
The national action would be taken by the future government to fix the "NHS and social care" in the country.
The health policy think tank said it would prioritise "improving access to out-of-hospital care", making "careers in health and social care" more attractive
and tackling the biggest risk factors affecting people's health.
It highlighted that workforce crisis is one of the biggest challenges faced by the National Health Service (NHS) and social care services in England while
citing "years of poor planning and fragmented responsibilities" as the reason for widespread staff shortages.
As per the King's Fund's data, there were more than 125,000 vacancies across the NHS workforce in England in October 2023, not including primary care vacancies
such as GPs, and 152,000 vacant posts in the adult social care workforce.
The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy
services.
It will also consider current challenges around funding, workforce and the digital infrastructure.
Planned developments within the profession will enable future pharmacists to be independent prescribers from day one of registration, giving them a greater role
within primary care teams.
Health and Social Care Committee Chair Steve Brine MP said: "It is clear that pharmacy has a central role to play in the future of the NHS. With a greater focus on
personalised and patient-centred healthcare, we will be asking what more must be done to make sure that the profession is in the best shape to meet demand.
"Better use of the pharmacy workforce would reduce pressures on general practice and hospitals. However, this will not happen without a planned workforce with the
funding, supervision and training to support it.
"At the end of the inquiry, the committee will be making recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is
realised.
Pharmaceutical Services Negotiating Committee has submitted its evidence to the House of Commons Health and Social Care Select Committee's recent inquiry into 'The future of General Practice'.
The committee, chaired by former health secretary Jeremey Hunt MP, had launched an inquiry to explore the future of NHS GP over the next five years.
PSNC's evidence focused on what community pharmacy is currently doing to support GPs, and what more can be done in the future.
The negotiator said: "We focused on how pharmacies supported patients throughout the pandemic as the only primary care access point offering healthcare advice on a walk-in basis.
Pharmacy leaders have called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across the
health service, including in community pharmacies.
A joint letter has been signed by representatives from 14 pharmacy organisations which highlights that with continued pressures on services, it is more important
than ever to support the pharmacy workforce so that the staff needed to deliver patient care now and into the future can be recruited, trained and retained.
Mark Koziol, Pharmacists' Defence Association (PDA) Chairman said: "Our pharmacist members practise across the entire health system and have the potential to do far
more to help patients and improve public health, but they can only do so safely if they are in appropriately staffed workplaces. This is a workforce issue, so it is
important that the Government works with representatives of the pharmacist workforce, and of their employers, to get a suitably agreed plan in place."
Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society (RPS), said: "It will be crucial to use the skills of all our health professions to support
the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.
Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal
Pharmaceutical Society (RPS).
RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association,
the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy.
It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration,
professional practice, education, leadership, management and research.
Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial
stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis.
The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of
genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation
plans published in England, Scotland and Wales.
Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare.
They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting
shared decision-making with patients and the multidisciplinary team.
Leading pharmacy bodies and associations are looking forward to working with 'reappointed' Secretary of State for Health and Social Care, Steve Barclay, on
'future roles' and 'funding' for the community pharmacy.
The Royal Pharmaceutical Society (RPS) England Country Board Chair, Thorrun Govind, hopes that the ministers will now be able to focus on addressing the key
challenges facing the health service and the country.
"This means not just getting through the winter, but planning for and investing in the future."
She added: "It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost
of long-term conditions, and deliver best value from medicines.
Politicians, researchers and pharmacy leaders called on the government to make community pharmacy a fundamental part of clinical services at an event at the
House of Commons on Wednesday (13).
At the launch of a research publication carried out by the University of Bath in conjunction with Sigma Pharmaceuticals, community pharmacy was described as
an "essential pillar of health care provision" in the UK.
The aim of this research was to provide evidence to support a strategy for the future developments of community pharmacy to ensure the sector continues to meet
the needs of the public in the NHS.
Researchers analysed 25 health and community pharmacy related policies published by the department of health, the NHS, the pharmacy profession, and spoke to
stakeholders from a wide range of backgrounds, including patients, pharmacists, NHS commissioners and GPS.
More pharmacies should do NHS Health Checks to improve access, a new study that focuses on ways to improve the lives of people living with obesity, recommends.
The report, Levelling Up Obesity Care, by pharma giant Novo Nordisk follows a series of roundtables with patient advocates, healthcare professionals and academics to generate understanding on the future of obesity care in England.
Amongst its recommendations, the report says that 'to widen access and alleviate pressure on GP services, consideration should be given to expanding NHS Health
Checks in community pharmacy'.
NHS Health Checks include a measurement of Body Mass Index (BMI).
Those most likely to benefit from a Health Check include people who live in more deprived areas, and are more likely to be living with obesity, says the report.
The pharmacy bodies have welcomed Health Select Committee's inquiry into pharmacy services and are calling the community pharmacies to engage fully.
On Thursday (8 June), MPs launched a new inquiry to examine the 'readiness of pharmacy services'. At the end of the inquiry, the committee will be making
recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is realised. It is currently seeking views and evidence
from anyone who can answer any or some of the questions listed here by Thursday 6 July.
National Pharmacy Association (NPA), Company Chemists' Association (CCA) and Royal Pharmaceutical Society (RPS) have confirmed that they will be submitting the
written evidence.
RPS said it will be submitting written evidence, and if they are called to give oral evidence they'll do so.
Malcolm Harrison, Chief Executive of the CCA commented: "We welcome the Health Committee's much-awaited inquiry into pharmacy. Whilst the recent announcement of
investment into the sector is welcome, this is new money for new activity. The historic underfunding of community pharmacy remains, and Primary Care Networks
(PCNs) continue to directly recruit community pharmacists.
The Department of Health (DoH) is inviting the public to share their views on a new Regional Obesity Management Service and a new Obesity Strategic Framework.
A public consultation has been launched on the Healthy Futures strategic framework, which aims to prevent the harm caused by obesity, and improve diets and levels
of physical activity of people.
The Department is also seeking views on its plans to introduce a new service that would focus on the introduction of specialist support, weight loss medication,
and bariatric surgery to help people living with obesity.
Northern Ireland is seeing an increase in obesity rates, with the latest Health Survey NI data showing that 65 per cent of adults and 26 per cent of children in
the country are either obese or overweight.
Community pharmacies are located within the very hotspots of peoples' communities, yet a staggering 720 individual businesses have stopped trading since 2015.
It has been called a "national disgrace and a betrayal to the elderly and the vulnerable" by sector leaders.
The funding crisis has been compounded by a gruelling 18-24 months post-Covid, both have which have placed immense pressure on the retail pharmacy sector.
The population is aging and with this comes patients living with a range of long-term health conditions. Medication regimes are becoming ever more complex and as a
result, maintaining prescription and medication adherence services is challenging to say the least.
Yet the public feel great warmth towards their local pharmacy businesses, and this positive attitude only increased during the pandemic. In fact, in a recent report
launched by Omnicell on the Changing Role of the Pharmacist, a survey of public opinion found that a third (32 per cent) said they perception of their local
pharmacy had changed for the better since the start of the pandemic and nearly half (44 per cent) said they are more familiar with their local pharmacy services
since the start of COVID.
This has meant that the role of the pharmacist has also changed and evolved; in part due to a national need and drive for more patients to be seen and supported
clinically by pharmacists.
This change of service provider role has slowly been developing over the last couple of years. Pharmacists are currently carrying out 65 million consultations
a year - a staggering rise of 44 per cent in the last 24 months alone.
Pharmacy bodies and MPs discussed on support needed to unlock the "full potential" of community pharmacy at the All Pharmacy Party Group (APPG)'s general
meeting held in Westminster on Tuesday (01 November).
The attendees of the meeting were Janet Morrison OBE, Chief Executive of Pharmaceutical Services Negotiating Committee; Malcolm Harrison, Chief Executive of The
Company Chemists' Association; Thorrun Govind, Chair of the Royal Pharmaceutical Society; Sanjeev Panesar, National Pharmacy Association Board Member, and Pharmacist
Superintendent and Owner of the Pan Pharmacy Group; and Sandeep Dhami, Association of Independent Multiple Pharmacies member and superintendent at MW Phillips Chemist
At the session, 18 parliamentarians were briefed on the myriad of ways pharmacies contribute to the health of the nation.
The panel of experts also highlighted that pharmacists are 'running out of fuel' with the growing challenges such as flat funding, workforce shortages and the
cost-of-living crisis impacting pharmacies' ability to deliver vital services.
In its response to the Health and Social Care Committee inquiry into 'Digital Transformation in the NHS', the Community Pharmacy IT Group (CP ITG) has
highlighted issues concerning the NHS community pharmacy.
CP ITG, of which PSNC is a member, has urged that pharmacy teams should have access to up-to-date records information, e.g. from Shared Care Records, GP Connect
and Summary Care Records with Additional Information.
It has also stated that the Booking and Referral Standards (BaRS) should be extended so that future referrals into and from pharmacy can be communicated seamlessly.
In its written response, CP ITG said: "Ensure that BaRS is expanded and aligns with other referral IT standards such as GP Connect referrals. Ensure it is used across
community pharmacy, the GP sector, other health care sectors and across the NHS, and by all health IT suppliers, so that messages and referrals can flow smoothly
within and across sectors and patients can have a seamless experience and safe care."
The group has asked the Health and Social Care Committee to create a framework for the development of pharmacy IT to ensure IT suppliers are better equipped to
support pharmacy teams and their delivery of services.
The Parliamentarians have called the government to urgently consider the short-term funding to stabilise the community pharmacy sector.
39 MPs and Peers from across the political spectrum have signed letters to the Health Secretary, Steve Barclay MP and raised their growing concern about the
pressures facing England's community pharmacies and the risks this poses to patient care and safety.
"Steve Barclay MP received correspondence from 23 Opposition MPs, with six Peers also signing a letter. Separately, 9 Conservative MPs also wrote to the Health
Secretary and up to 10 others have signalled their intention to write to the relevant Minister," said the Pharmaceutical Services Negotiating Committee (PSNC).
The Parliamentarians acknowledged that pharmacies have the potential to do more to support the NHS and they called for the government to urgently consider a
commitment to working with the sector to create a fair and fit for purpose future funding model that ensures sustainability and properly funds pharmacies for what
they do.
All signatories also called for the introduction of a fairly-funded Pharmacy First service.
Community Pharmacy England has submitted a full and detailed written response to the Health and Social Care Select Committee's pharmacy inquiry.
The Committee is expected to hold oral evidence sessions when Parliament returns in the Autumn. The commencement of this inquiry follows on from those held on
other primary care sectors, including Dentistry and General Practice.
According to the Committee website this inquiry 'will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and
hospital pharmacy services'.
Key themes of CPE's submission include- Suggestions on future service provision; Challenges with the pharmacy workforce; Longstanding underfunding of the sector;
and Current pressures.
Janet Morrison OBE, Chief Executive of Community Pharmacy England, said: "This is an extremely important opportunity for all who work with and in the Pharmacy
sector, to highlight not only the extreme challenges we face, but also ideas and suggestions for what more we can do to help patients and the public in the future.
A policy brief, developed by researchers from the University of Bath and University of Strathclyde with funding from Sigma Pharmaceuticals, has recommended
the Department of Health and Social Care (DHSC) and NHS to increase community pharmacy funding to avoid damaging closures and diminution of quality.
The report launched on Wednesday (12 June) at an event in the House of Commons, attended by Members of Parliament, senior policymakers and the pharmacy industry,
analysed community pharmacy policies and spoke to stakeholders to explore their opinions of the future of community pharmacy.
It was found that patients value their community pharmacies, but staff feel demotivated, insecure and undervalued.
Stakeholders and policies suggested that in the future, medicines should be supplied by automated 'hub and spoke' dispensing, enabling community pharmacy staff to
provide services that relieve pressure on GP surgeries, such as long-term conditions management, urgent care and public health.